Key facts, as of
As of October 6, 2026, Colgate-Palmolive (CL) trades at $87.25, up 12.7% over the past year. Its 52-week range runs from $74.55 to $99.33; the price is 12.2% below that high. It is 20.2% below its all-time high of $109.30, reached in September 2024. Over the 10 years to the end of September 2026, with dividends reinvested, it returned +45.7%, against +312.9% for the S&P 500 (SPY). It sits 1.5% below its 200-day average of $88.55, the usual sign of a long-term downtrend. Its 30-day volatility is 16.1% annualized, which we rate medium risk. It has a trailing P/E of 34.4 and a dividend yield of 2.46%.
Cite: Portfolio Terminal, "Colgate-Palmolive (CL) stock analysis", 2026-10-06. https://portfolio-terminal.com/analyse/cl
Where it trades today
trading 51% of the way up its 52-week range
How the price has moved
How far it is from its record
Colgate-Palmolive (CL) is 20.2% below its all-time high of $109.30, reached in September 2024. Over the 10 years to the end of September 2026, with dividends reinvested, it returned +45.7%, against +312.9% for the S&P 500 (SPY).
What to weigh before acting
What Matters Now
- The key question is whether steady demand and pricing discipline can protect margins even if growth stays modest.
- CL trades at 34.4x earnings, well above the consumer defensive average of 21.0x, so the market is already pricing in above-consensus execution.
- CL carries a beta of 0.32, which means the stock should be judged on how it affects total portfolio swings, not just on standalone upside.
- Relative performance versus PG, KO, PEP matters here because leadership inside consumer defensive rarely stays static for long.
Portfolio Use Case
- CL is more relevant for investors who want some income support alongside price appreciation, not just pure growth exposure.
- The beta profile suggests it can fit a quality or lower-volatility sleeve more naturally than a high-octane tactical basket.
- This page is most useful for deciding whether the stock deserves a permanent slot in the portfolio or just a place on the watchlist.
What Would Change the View
- A reset in earnings expectations or a faster peer catch-up could compress the premium valuation currently embedded in CL.
- The view would need revisiting if peers such as PG, KO, PEP start winning the marginal flow or posting cleaner operating momentum.
Methodology
- Price, market cap, beta, yield, and liquidity fields for CL come from Yahoo Finance quote and summary data.
- 30-day volatility is calculated from recent daily returns and annualized using a 252-trading-day convention.
- Sector context uses stored benchmark averages for Consumer Defensive so each page compares the ticker against a stable peer baseline rather than against the whole market.
- Peer comparisons use the Portfolio Terminal coverage set and highlight nearby listed alternatives such as PG, KO, PEP.
Sources
- Yahoo Finance quote dataopen →
Live quote, valuation, beta, yield, and volume fields used for CL. Last refresh: Oct 6, 2026, 11:07 PM.
- Portfolio Terminal methodologyopen →
Explains how analytics, refresh cadence, and portfolio interpretation work across the product.
- Peer set and coverage context
Comparative context for this page is anchored around nearby tracked names such as PG, KO, PEP.
What Colgate-Palmolive does
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick,…
Employees
33,600
Industry
Household & Personal Products
Headquarters
New York, United States
What analysts expect
CL carries a buy consensus from 20 analysts, with an average price target of $98.35 versus $87.25 today (+12.7%). Targets are estimates and can move quickly after earnings.
Consensus aggregated by Yahoo Finance. Targets are estimates, not forecasts.
How the business is doing
CL generated $21.05B in trailing revenue (4.9% year over year), with a 9.7% net margin, and $3.46B of free cash flow, against $6.40B of net debt.
The numbers, year by year
| Fiscal year | Revenue | Gross profit | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|---|
| 2025 | $20.38B | $12.25B | $4.23B | $2.13B | $2.64 | $3.63B |
| 2024 | $20.10B | $12.16B | $4.33B | $2.89B | $3.53 | $3.55B |
| 2023 | $19.46B | $11.33B | $4.08B | $2.30B | $2.78 | $3.04B |
| 2022 | $17.97B | $10.25B | $3.62B | $1.78B | $2.13 | $1.86B |
When it reports next
Estimates aggregated by Yahoo Finance. Dates move and estimates change until the report lands.
Which ETFs hold it
CL is in 8 of the 30 ETFs we track. It weighs most in XLP: 4.39% of the fund, holding #9 of 33.
Famous investors who hold it
CL is in the latest 13F of 1 of the 15 famous investors we follow. Renaissance Technologies (Founded by Jim Simons) holds the most of it: 0.11% of the portfolio, position #202 of 2,931, as of Q2 2026.
How it sits in consumer defensive
Stable sector with essential products like food, beverages, and household goods.
The companies it competes with
CL beside the consumer defensive names it is usually measured against.
What the chart is saying
Slipped under its 50-day average inside a longer uptrend.
weakening- Price is 2.5% below its 50-day average and 1.5% below its 200-day.
- RSI at 50 is neither stretched nor washed out.
- The nearest ceiling is $89.30 (+2.4%), the nearest floor $86.44 (-0.9%).
A description of the chart, not advice. Indicators describe what the price has done; none of them knows what it does next.
Questions people ask about it
Is CL a good investment in 2026?
Colgate-Palmolive trades at a P/E ratio of 34.4, with medium volatility (16.1% annualized). The stock is in a consolidation phase.
What is the risk level of CL?
Based on 30-day volatility of 16.1%, CL has MEDIUM risk. Beta of 0.32 indicates lower sensitivity to market movements than average.
Does CL pay dividends?
Yes, Colgate-Palmolive has a dividend yield of 2.46%.
How far is CL from its all-time high?
Colgate-Palmolive is 20.2% below its all-time high of $109.30, reached in September 2024. Over the 10 years to the end of September 2026, with dividends reinvested, it returned +45.7%, against +312.9% for the S&P 500 (SPY).
Which ETFs hold CL?
8 of the 30 popular ETFs we track hold Colgate-Palmolive. The largest weights: XLP (4.39%), VIG (0.31%), VYM (0.29%), VTV (0.26%) and VOO (0.11%). Measured on each issuer's full holdings file, dated August 31 to September 24, 2026.
How much of VOO is CL?
0.11%, as of August 31, 2026: CL is holding #169 of 505 in Vanguard's file for VOO. $1,000 in VOO puts about $1.09 in Colgate-Palmolive.
Which famous investors own CL?
Renaissance Technologies (0.11% of Founded by Jim Simons's 13F), according to their latest Form 13F filings with the SEC (Q2 2026). A 13F lists US long positions 45 days after the quarter ends, so it can be out of date.
What is the analyst price target for CL?
The average analyst price target for Colgate-Palmolive (CL) is $98.35 based on 20 analyst estimates, about 12.7% above the current price of $87.25. The published range runs from $87.00 to $110.00.
How much revenue does CL generate?
Colgate-Palmolive reported $21.05B in trailing twelve-month revenue. Revenue growth is running at 4.9% year over year. Net margin sits at 9.7%. Figures are aggregated from company filings by Yahoo Finance and refresh on an hourly cadence.
Compare CL with anything
Five years side by side: what $10,000 became, how far each fell, whether they move together.